/
CLBT
$14.12+$0.36 (+2.58%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.4B
249M shares
52-week range
$11.02 – $19.98
35% from low
Exchange
NASDAQ
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$3.87
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $171.9M | $194.9M | $246.2M | $270.7M | $325.1M | $401.2M | $475.7M |
| Cost of revenue | $35.8M | $37.9M | $42.6M | $50.7M | $53.2M | $62.6M | $75.2M |
| Gross profit | $136.0M | $157.0M | $203.7M | $219.9M | $271.9M | $338.6M | $400.5M |
| Gross margin | 79.2% | 80.6% | 82.7% | 81.3% | 83.6% | 84.4% | 84.2% |
| R&D | $46.6M | $54.4M | $65.5M | $80.6M | $84.4M | $98.4M | $113.9M |
| Operating income | −$1.5M | $9.2M | $13.8M | $1.0M | $33.2M | $56.9M | $66.5M |
| EBITDA | $5.6M | $17.3M | $89.5M | $130.1M | −$65.4M | −$265.3M | $103.1M |
| Net income | −$1.9M | $5.8M | $71.4M | $120.8M | −$81.1M | −$283.0M | $78.3M |
| Net margin | -1.1% | 3.0% | 29.0% | 44.6% | -24.9% | -70.5% | 16.5% |
| EPS (diluted) | -0.05 | -0.05 | 0.44 | 0.59 | -0.43 | -1.35 | 0.31 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $568M | $0.33 | $0.31–$0.34 | 5 |
| 2027 | $667M | $0.44 | $0.41–$0.47 | 5 |
| 2028 | $783M | $0.57 | $0.54–$0.60 | 2 |
| 2029 | $865M | $0.91 | $0.90–$0.93 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Cellebrite DI Ltd. Class A Ordinary Shares
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
www.cellebrite.com- Employees
- 1,285
- IPO / List date
- Aug 31, 2021
Held by traders on TradeandTell
No one on the platform currently holds CLBT.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CLBT as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CLBT yet.
